CMPS
CMPS
US20451W1018
COMPASS Pathways Plc - American
Loading chart...

Company Profile

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.

Latest News

Cathie Wood-Led Ark Invest Sells AMD, SPCX, GOOG Stocks — But Loads Up On CMPS, NTLA, CRSP And Other Healthcare Firms
AMDSPCXGOOG
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CMPSCOMP
COMPASS Pathways (CMPS) Could Be 49% Below Fair Value Following Its Phase III Progress
CMPSCOMP
Compass Pathways Appoints Kelley Boucher as Chief People Officer
COMPCMPS
Compass Pathways Targets Q4 COMP360 NDA Completion, Eyes 2027 Launch
CMPS
Helus Pharma Eyes Q4 Phase III Data for HLP-003 in Major Depression
CMPS

Related stocks

CVSG.L
CVSG.L • United Kingdom
CVS GROUP PLC ORD 0.2P
1,173 GBp
1.05B USD 1Y -18.6%
SPI.L
SPI.L • United Kingdom
SPIRE HEALTHCARE GROUP PLC ORD
247 GBp
1.31B USD 1Y +2.5%
4018.SR
4018.SR • Saudi Arabia
Almoosa Health Co.
116.6 SAR
1.38B USD 1Y -36.9%
PARKHOSPS.NS
PARKHOSPS.NS • India
PARK MEDI WORLD LIMITED
270.8 INR
1.21B USD
ATT.ST
ATT.ST • Sweden
Attendo AB
120 SEK
1.68B USD 1Y +76.1%
4019.SR
4019.SR • Saudi Arabia
Specialized Medical Co.
14.84 SAR
988.02M USD 1Y -25.8%
MCOV-B.ST
MCOV-B.ST • Sweden
Medicover AB ser. B
263.5 SEK
4.01B USD 1Y -0.8%
AGL
AGL • United States
agilon health, inc.
82.39 USD
1.38B USD 1Y +210.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics
Country
United Kingdom
Region
Europe
Sector
Healthcare
Industry
Medical Care Facilities
Website
https://compasspathways.com

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
80.6% p.a.
Max Drawdown (5Y)
-95.2%
Sharpe Ratio (5Y)
-0.26
Beta Factor
2.56
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
High market risk: Beta of 2.56 indicates above-average volatility compared to the broader market.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Elevated Short-Term Volatility: 3Y volatility (84.8%) is noticeably higher than the 5Y average (80.6%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (80.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -95.2% in the extended horizon.
ende